<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR211.html">Part 211
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 211.184  Component, drug product container, closure, and labeling
                            </h3>
                            <p class="depth0">These records shall include the following:</p><p class="depth1"><em>(a)</em> The identity and quantity of each shipment of each lot of  components, drug product containers, closures, and labeling; the name of  the supplier; the supplier's lot number(s) if known; the receiving code  as specified in Sec. 211.80; and the date of receipt. The name and  location of the prime manufacturer, if different from the supplier,  shall be listed if known.</p><p class="depth1"><em>(b)</em> The results of any test or examination performed (including  those performed as required by Sec. 211.82(a), Sec. 211.84(d), or  Sec. 211.122(a)) and the conclusions derived therefrom.</p><p class="depth1"><em>(c)</em> An individual inventory record of each component, drug product  container, and closure and, for each component, a reconciliation of the  use of each lot of such component. The inventory record shall contain  sufficient information to allow determination of any batch or lot of  drug product associated with the use of each component, drug product  container, and closure.</p><p class="depth1"><em>(d)</em> Documentation of the examination and review of labels and  labeling for conformity with established specifications in accord with  Sec. Sec. 211.122(c) and 211.130(c).</p><p class="depth1"><em>(e)</em> The disposition of rejected components, drug product containers,  closure, and labeling.</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
